Small molecule inhibitors of MYC and uses thereof
US11214567B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 23, 2018 |
| Grant date | Jan 4, 2022 |
| Priority date | — |
| Expiry date | Aug 25, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having an oxadiazole-oxadiazolone structure (e.g., oxadiazole-phenyl-oxadiazolone compounds, oxadiazole-pyridine-oxadiazolone compounds, oxadiazole-indole-oxadiazolone compounds, oxadiazole-quinoline-oxadiazolone compounds, oxadiazole-pyrrole-oxadiazolone compounds, and oxadiazole-vinyl-oxadiazolone compounds), and their use as therapeutics for the treatment of cancer and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.